Wednesday 27 December 2017

Medical Oxygen Concentrators Market to grow at a CAGR of 10% from 2016 to 2023

Medical Oxygen Concentrators Market outlook is positively influenced by advancements in healthcare system along with a strong desire to maintain good health. The medical expenditure is observing a significant upsurge, one of the several reasons being the elderly population suffering from acute respiratory disorders.

As per the UN report, aging population is expected to reach over 2 billion by 2050. The increasing geriatric population base is estimated to be a prime factor driving the medical oxygen concentrators industry trends over the coming years. As per Global Market Insights, Inc., “Medical oxygen concentrators market size is expected to hit USD 2.3 billion by 2023.” Moreover, favorable medical insurance as well as reimbursement policies are expected to offer lucrative avenues for the global industry landscape.

Order This Report by calling Global Market Insights, Inc. at 1-888-689-0688 (Toll Free) or 1-302-846-7766.

The differentiating factor of Medical Oxygen Concentrators market report by Global Market Insights, Inc. when compared with other, similar syndicated research studies includes a 360-degree synopsis of trends for a period of more than 10 years including historic information as well as future outlook. Business focussed multiple trends for Medical Oxygen Concentrators industry are discussed along with regional trends to offer an overall view of the market. The ‘industry insights’ chapter of this research provides the most comprehensive analysis of Medical Oxygen Concentrators market covering segmentation, size, forecasts, ecosystem analysis and more. Industry impact forces (regional and global) that cover growth drivers and challenges, growth potential analysis, a strategy dashboard for competitive landscape of Medical Oxygen Concentrators market support this sector specific data and information points.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/449

Portable and fixed medical oxygen concentrators are the two major product segments of the medical oxygen concentrators market. High popularity of lightweight and user friendly concentrators is expected to enhance portable medical oxygen concentrators market value over the coming six years. Furthermore, its prominent use across shopping malls, airports, and offices is projected to fuel the product demand. Favorable government initiatives encouraging the use of FAA (Federal Aviation Administration) compliant portable medical oxygen concentrators in aircraft is further expected to propel the portable medical oxygen concentrators industry growth over the period of 2016-2023.
Fixed medical oxygen concentrators industry, which made significant contributions towards the overall revenue in 2015, is expected to witness a noticeable growth over the next few years, driven by the rapid increase in the aging population susceptible to respiratory disorders.
Medical oxygen concentrators find wide applications in home care and non- home care sectors. Medical oxygen concentrators market is predicted to observe a lucrative growth in the home care sector over the coming six years. Increase in the number of severely affected COPD patients requiring oxygen therapy at home along with the affordability and efficiency of this system will propel the medical oxygen concentrators industry size in home care sector.
High demand for medical oxygen concentrations in non-home care sector due to rising elderly population base susceptible to the occurrence of chronic ailments such as asthma, respiratory ailments, lung disorders, and COPD is expected to push the industry revenue.
Browse key industry insights spread across 86 pages with 54 market data tables & 6 figures & charts from the report Medical Oxygen Concentrators Market in detail along with the table of contents:


On account of the global trends, North America medical oxygen concentrators market, which contributed over 40% towards the overall revenue, is expected to grow significantly over the coming timeframe, driven by factors such as the high occurrence of respiratory ailments, beneficial reimbursement norms, and growing product demand across the home healthcare sector. Furthermore, the high occurrence of COPD due to irregular life patterns is expected to drive the regional growth. U.S. is forecast to be a key regional revenue contributor.
APAC medical oxygen concentrators industry will also observe significant growth over the coming years, owing to the high living standards, rapidly increasing older population base, and better healthcare facilities. China and India are anticipated to be the major regional revenue pockets.
Latin America medical oxygen concentrators market is slated to register a high growth over the next few years, driven by factors such as high investments in healthcare infrastructural expansion, rising awareness among the patients about early diagnosis, and growing popularity of portable medical oxygen concentrators. Brazil is expected to make significant contributions towards the regional share.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/449
Heavy demand for medical oxygen concentrators in Europe, owing to inadequacy of pure oxygen supply accompanied by introduction of beneficial compensation policies by the government will drive the regional growth.UK and Germany are estimated to be the key growth drivers of the region.
Key industry participants include Advanced Technocracy Incorporation, Teijen, O2 Concepts, Philips Respironics, AirSep, Goodhealth Incorporation, DeVilbiss Healthcare, and Covidien Limited.
Browse Related Reports:

Homecare Oxygen Concentrators Market Size By Product (Portable Oxygen Concentrators, Compressed Gas Oxygen Cylinders, Liquid Oxygen), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, China, Japan, Brazil, South Africa), Price Trends, Competitive Market Share & Forecast, 2016 – 2023

https://www.gminsights.com/industry-analysis/homecare-oxygen-concentrators-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Precision Medicine Market share to see growth of 10.5% from 2017 to 2024

One of the pivotal factors influencing precision medicine market size in recent times is the emerging approach for disease diagnosis & prevention that is calculated based on the genes and lifestyle of a person. Research claims that the precision medicine approach will help researchers and doctors to forecast the type of treatment that a patient would require and the kind of preventive measures that would be required for selective diseases. Considering the significant mark that this approach has made in the healthcare sector, precision medicine industry giants have been striving to exploit the potential of this technology to improve the accuracy of day-to-day healthcare.
Recently for instance, The Michael J. Fox Foundation has collaborated with 23andMe and invested USD 4 million to construct a research facility for Parkinson’s disease treatment using precision medicine. This collaboration will reportedly open up potential opportunities for researchers to improvise on genetic biology with excellent drug designing related to precision medicine. The prevalence of scientific partnerships such as these among the biotechnology companies and research organizations will impel precision medicine market share.
Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/671
As of today, next generation sequencing (NSG) technologies have been making their mark in precision medicine industry, driven by reduced expenditure, understanding of the genetic know-how of diseases, and high throughput sequencing. The prevalence of NSG technologies may specifically have an impact on U.S. precision medicine market, given the vast expanse of the healthcare and medical research verticals across the region.
Driven by the substantial adoption of NGS panels in precision medicine, U.S. accounted for the largest regional share of precision medicine market in 2016. The U.S. government has also been enforcing regulatory norms and undertaking favorable initiatives to generate awareness among the populace regarding the benefits of the precision medicine approach which would further help augment U.S. precision medicine market.
Browse key industry insights spread across 110 pages with 64 market data tables & 09 figures & charts from this 2017 report Precision Medicine Market in detail along with the table of contents at:

Regional governments have been going the whole hog to promote the usage of precision medicine systems via funding and private-public partnerships. In Australia for example, the government has been providing substantial funding to numerous companies and upcoming entrepreneurs to invest in precision medicine industry and the 3D printing technology.
Initiatives of a similar kind undertaken by governmental bodies across numerous geographies are likely to augment the overall precision medicine market. Speaking of which, NanoString Technologies, Novartis, Intomics, Biocrates Life Sciences, Tepnel Pharma Services, Roche, Silicon Biosystems, Ferrer InCode, Novartis, LabCorp, Quest Diagnostics, and Medtronic are some of the names that have been accumulating a commendable share of precision medicine industry.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/671

Research institutes have been giving substantial preference for precision medicine given that the technology helps diagnose children with cancer. The computational approach of precision medicine to share the patient’s database across the globe will transform the healthcare sector over the coming years. In addition, precision medicine has the capability to enhance personalized healthcare through disease detection at an earlier stage and supplying sufficient information regarding the progression of disease.
Speaking along the same lines, it is prudent to mention that the quality, affordability, and accessibility of healthcare systems has improved substantially due to the emergence of precision medicine. The surging adoption of this technology for care delivery, clinical outcomes, operational performance, and clinical workflows will thus propel precision medicine industry share in the forthcoming years. According to a precision medicine market research report put together by Global Market Insights, Inc., this business vertical is slated surpass a revenue collection of USD 96 billion by the end of 2024.
Browse Related Reports:

Compounding Pharmacies Market Size By Product (Oral, Topical, Rectal, Parenteral, Inhaler, Ophthalmic), By Application (Paediatric, Adult, Geriatric, Veterinary), By Therapeutic Area (Hormone Replacement, Pain Management), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, France, Spain, Russia, Poland, Greece, Ukraine, Sweden, Norway, Belgium, Czech Republic, Finland, China, India, Japan, Singapore, Australia, Brazil, Mexico, Saudi Arabia, UAE, South Africa, Qatar, Kuwait), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Tuesday 19 December 2017

Precision Medicine Market to witness more than 10.5% CAGR from 2017 to 2024

The research report “Precision Medicine Market Size By Technology (Big Data Analytics, Gene Sequencing, Drug Discovery, Bioinformatics, Companion Diagnostics), By Application (Oncology, CNS, Immunology, Respiratory), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Scandinavia, Italy, Japan, China, India, Singapore, Mexico, Brazil, South Africa, UAE, Qatar, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024” by Global Market Insights, Inc. says, Precision Medicine Market size is set to exceed USD 96 billion by 2024.

Rising prevalence of cancer across the globe fuels the need to develop target specific biomarkers based on the individual genetic, environmental and lifestyle factors augmenting the global precision medicine market size. Advancement in cancer biology coupled with increased funding for cancer research will fuel industry expansion. For instance, in 2015 NIH’s National Cancer Institute (NCI) invested USD 70 million to develop effective therapies for the treatment of cancer based on the individual genomic data.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/671

Presence of favorable government initiatives such as Precision Medicine Initiative (PMI) with an aim to design tools for analyzing large medical data sets, validation of innovative targeted drugs, tests and technologies for cancer, improve decision making for treatment options for specific patients will augment growth of precision medicine market.

Integration of big data analytical tools to healthcare for preventing diseases such as cancer is another growth rendering driver. Moreover, rising adoption of gene therapy to reduce cost burden for such diseases will favor industry expansion. Excessive cost associated with precision medicine coupled with misinterpretation of genomic data will hamper business growth.

Drug discovery dominated the precision medicine market in 2016 followed by gene sequencing which is expected to show a considerable growth over the coming years. Availability of next generation sequencing based genetic tests for rapid sequencing and identification of large human genome along with favourable regulatory guidelines by U.S. FDA for validation of such genetic tests is a major advancement in precision medicine accelerating gene sequencing revenue growth.

Browse key industry insights spread across 110 pages with 64 market data tables & 09 figures & charts from this 2017 report Precision Medicine Market in detail along with the table of contents at:


Companion diagnostics is poised to be the fastest growing segment with over 11.5% CAGR owing to its ability to provide essential information for the safety and effectiveness of a specific drug or therapeutic product for targeted patient groups.

CNS will show considerable growth over the coming years owing to the rising economic burden of central nervous system disorders which fosters the need to develop genomic platforms in combination with electronic health record data based on clinical phenotypes for effective targeted treatment of such diseases.

UK precision medicine market should witness robust growth over the forecast period. Favorable government initiatives and increasing funding on research activities such as the launch of stratified medicine initiative in 2011 with €60 million budget focused on biomarker, patient cohorts, genomic and phenotypic analysis will fuel regional growth. Further, the launch of 100,000 Genomes Project in 2012 by Genomics England with €250-300 million funding for genomics has paved the way for individualized treatment for cancer patients and escalate regional market size.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/671

India precision medicine market should grow at significant rate due to increasing prevalence of cancer which fuels the adoption of gene therapy facilitating personalized treatment for patients based on their genetic factors. Emergence of big data in healthcare and government initiatives to improve healthcare infrastructure of the country are driving factors for industry growth.

Some of the key industry players operating in global precision medicine market are NanoString Technologies, Roche, Medtronic, Laboratory Corporation of America Holdings, Quest Diagnostics, Pfizer, Novartis and Intomics.

The industry players attempt to develop cost-effective solutions and tools for efficient decision making and selecting effective treatment options for treatment of chronic diseases. For instance, in March 2017, NanoString Technologies launched new products such as nCounter Low RNA Input Kit, nCounter Myeloid Innate Immunity Panels at the American Association of Cancer Research (AACR) meet. This strategic move extends the existing product portfolio offered by the firm and leverages proteomics & genomics to advance the field of precision oncology.

Browse Related Reports:

Antidiabetics Market Size By Product (Insulin [Rapid Acting, Long Acting, Premixed, Short Acting, Intermediate Acting], Alpha-Glucosidase Inhibitors, Biguanides, Sulphonylureas, GLP-1 Agonist, Meglitinides, DPP-4 Inhibitors, SGLT-2, Thiazolodinediones), By Application (Type I Diabetes, Type II & Other), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023


About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Monday 18 December 2017

In-Vitro Colorectal Cancer Screening Tests Market to grow at over 5% CAGR from 2016 to 2023

The research report In-Vitro Colorectal Cancer Screening Tests Market Size By Test Type (Fecal Occult Blood Tests [Guaiac FOB Stool, Immuno-FOB Agglutination, Lateral Flow Immuno-FOB, Immuno-FOB ELISA], Biomarker Tests [Tumor M2-PK Stool, Transferrin Assays], CRC DNA Screening Tests [Methylated Gene Testing, Panel DNA Tests]), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Japan, China, Brazil, Mexico, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023”, by Global Market Insights, Inc., says In-vitro colorectal cancer screening tests industry size is estimated to hit USD 903 million by 2023.

Technological developments in healthcare to acquire accurate results in early diagnosis will propel in-vitro colorectal cancer screening tests market size over the coming years. Furthermore, government legislations mandating cancer diagnosis and screening are expected to boost the market trends. For instance, EU collaborated with IARC (International Agency for Research on Cancer) to produce the first edition of quality assurance guidelines for colorectal cancer diagnosis and screening to improve the quality of cancer diagnosis. Moreover, rise in the geriatric population base, prone to chronic diseases, along with the escalating occurrence of colon and rectal cancer is expected to favorably impact in-vitro colorectal cancer screening tests market growth over the next few years. In addition to this, growing awareness about early diagnosis of colorectal cancer will noticeably enhance the industry outlook.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/451

Order This Report by calling Global Market Insights, Inc. at 1-888-689-0688 (Toll Free) or 1-302-846-7766.

The differentiating factor of in-vitro colorectal cancer screening tests market report by Global Market Insights, Inc. when compared with other, similar syndicated research studies includes a 360-degree synopsis of trends for a period of more than 10 years including historic information as well as future outlook. Business focussed multiple trends for in-vitro colorectal cancer screening tests industry are discussed along with regional trends to offer an overall view of the market. The ‘industry insights’ chapter of this research provides the most comprehensive analysis of in-vitro colorectal cancer screening tests market covering segmentation, size, forecasts, ecosystem analysis and more. Industry impact forces (regional and global) that cover growth drivers and challenges, growth potential analysis, a strategy dashboard for competitive landscape of in-vitro colorectal cancer screening tests market support this sector specific data and information points.

Rising popularity of fecal occult blood tests is projected to boost in-vitro colorectal cancer screening tests industry share over 2016-2023:

Taking into consideration the tests trends, in-vitro colorectal cancer screening tests market is segmented into biomarker tests, fecal occult blood tests, and colorectal cancer(CRC) DNA screening tests. Growing use of Immuno- fecal occult blood agglutination as well as Immuno- fecal occult blood ELISA tests for early and quick detection of colorectal cancer will boost FOB tests market size, having attained targeted revenue of over USD 500 million in 2015. Colorectal cancer (CRC) DNA screening tests market size is expected to grow at a rate of 10% over the period of 2016-2023, owing to high level of test accuracy and sensitivity.


https://www.gminsights.com/industry-analysis/in-vitro-colorectal-cancer-screening-tests-market-report

Asia Pacific is expected to drive in-vitro colorectal cancer screening tests industry revenue by 2023:
Considering the regional outlook, North America in-vitro colorectal cancer screening tests market, which dominated the regional landscape in 2015, is projected to witness a considerable growth over the coming years, driven by rise in healthcare spending, enhanced healthcare amenities, high level of patient awareness, and introduction of supportive government legislations related to screening tests. U.S. is expected to be a key regional revenue pocket.

Moreover, recommendation of introducing effective screening tests in healthcare sector by EU along with favorable changes in existing tests will drive Europe in-vitro colorectal cancer screening tests industry revenue over the coming years. In addition to this, the growing significance of colorectal cancer screening tests in Europe has significantly reduced the mortality rate. Germany is forecast to make significant contributions towards the regional share.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/451

Market players will try to increase regional presence through strategic alliances and exploration of untapped opportunities in emerging economies. Key industry participants include Eiken Chemical Company Limited, Abbott Molecular, CompanionDx Reference Lab LLC, Alere Incorporation, Sysmex Corporation, Quest Diagnostics, Beckman Coulter, Merck Millipore Corporation, and Epigenomics AG.

Browse Related Reports:

Cancer Biological Therapy Market Size By Product (Monoclonal Antibodies [Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bi-Specific Monoclonal Antibodies], Vaccines [Preventive, Therapeutic], Cancer Growth Blockers [Tyrosine Kinase Inhibitors, Proteasome Inhibitors, mTOR Inhibitors], Blood Cell Growth Factors [Lenograstim, Filgrastim], Cytokines [Interferons, Interleukins]), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

https://www.gminsights.com/industry-analysis/cancer-biological-therapy-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Thursday 14 December 2017

Therapeutic Respiratory Devices Market to grow at 11.7% CAGR from 2016 to 2024

Therapeutic Respiratory Devices Market share is propelled due to rising geriatric population, growing adoption of advanced therapeutic devices, and continuous surge in COPD patients due to increasing pollution level and cigarette smoking. Therapeutic respiratory devices market is on the rise due to the growing prevalence of respiratory diseases such as asthma and chronic obtrusive pulmonary diseases (COPD). COPD is one of the leading causes of demises globally.

According to Global Market Insights, Inc., “Therapeutic Respiratory Devices Market size worth USD 8.5 billion in 2015, is estimated to grow at a CAGR of 11.7% over the period of 2016-2024.”  These devices are used in the treatment of range of diseases including obstructive sleep apnea, asthma, cystic fibrosis, respiratory distress syndrome, chronic obstructive pulmonary disease, and pneumonia.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/696  

Japan has the largest geriatric population, owing to which Japan therapeutic respiratory devices industry is projected to exceed USD 2 billion by 2024, having had a revenue of USD 750 million in 2015. Moreover, growing health awareness and expansion in healthcare industry will drive the regional growth. Brazil therapeutic respiratory devices market is anticipated to register a CAGR of 13% over the period of 2016-2024.
The global therapeutic respiratory devices market is segmented on the basis of products, filters and technology. Growing adoption of therapeutic products and filters such as Nebulizers, Gas Analyzers, Capnographs, Humidifiers, Oxygen Concentrators and PAP devices will spur therapeutic respiratory devices market growth. Oxygen concentrators is anticipated to grow at a rate of 12.4% CAGR over the period of 2016-2024, owing to improved healthcare services and growing awareness in low-income regions. Pneumatic Nebulizers Market size was worth over USD 1 billion and accounted for 13% therapeutic respiratory devices industry share. Moreover, positive airway pressure (PAP) devices accounted for over 55% of overall industry share in 2015. The humidifier filters are widely used in hospitals, home, schools, and healthcare entities and is anticipated to grow at a rate of 12.5% over the period of 2016-2024.
Browse key industry insights spread across 126 pages with 60 market data tables & around 10 figures & charts from this 2017 report Therapeutic Respiratory Devices Market in detail along with the table of contents at:

The introduction of technological innovations such as Electrostatic Filtration, Microsphere Separation, Hollow Fiber Filtration, and HEPA filter technology are expected to serve as future growth opportunities for therapeutic respiratory devices market. Electrostatic filtration revenue is projected to witness over 11.5% CAGR over the period of 2016-2024, owing to its wide acceptance and easy maintenance. Moreover, HEPA filter technology accounted for 35% of therapeutic respiratory devices market share in 2015 due to its effective air filtration technique and wide span of applications.

Geographically, North America accounted for the largest industry share, and was pegged at USD 3 billion in 2015. US therapeutic respiratory devices market share is anticipated to witness a CAGR of 10.8% over the period of 2016-2024, owing to large pool of COPD patients and promising regulatory scenario.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/696

Over the coming years, therapeutic respiratory devices industry players will adopt business strategies such as mergers, collaborations & strategic alliances, and R&D investments, focused on expanding their product portfolio. Key companies include GE Healthcare, CareFusion, Covidien, Invacare, Smiths Medical, Philips Healthcare, etc.

Browse Related Reports:

Pneumatic Nebulizers Market Size By Product (Breath-Actuated, Vented), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Spain, Italy, Japan, China, India, South Africa, Brazil, Mexico), Unit Shipments, Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

https://www.gminsights.com/industry-analysis/pneumatic-nebulizers-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.


Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:
sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter